These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1951242)
1. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate. Miyoshi H; Ohshiba S; Matsumoto A; Takada K; Umegaki E; Hirata I Am J Gastroenterol; 1991 Nov; 86(11):1638-41. PubMed ID: 1951242 [TBL] [Abstract][Full Text] [Related]
2. [Study on the usefulness of haptoglobin used on endoscopic injection sclerotherapy]. Matsumoto A; Miyoshi H; Takada K; Hayashi K; Asada S; Hirata I; Ohshiba S Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1343-9. PubMed ID: 2214258 [TBL] [Abstract][Full Text] [Related]
3. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant. Hashizume M; Kitano S; Yamaga H; Sugimachi K Lancet; 1988 Aug; 2(8606):340-1. PubMed ID: 2899760 [No Abstract] [Full Text] [Related]
4. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy. Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932 [TBL] [Abstract][Full Text] [Related]
5. [The prophylactic effect of haptoglobin administration on renal disfunction in endoscopic injection sclerotherapy]. Miyoshi H; Oshiba S; Matsumoto A; Hayashi K; Tei H Nihon Shokakibyo Gakkai Zasshi; 1989 Feb; 86(2):280. PubMed ID: 2754835 [No Abstract] [Full Text] [Related]
6. Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate. Bellary SV; Isaacs P Endoscopy; 1990 May; 22(3):151. PubMed ID: 2357939 [No Abstract] [Full Text] [Related]
7. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices. Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669 [TBL] [Abstract][Full Text] [Related]
8. Sclerotherapy for esophageal varices. Benjamin SB DICP; 1990 Nov; 24(11 Suppl):S47-50. PubMed ID: 2270696 [TBL] [Abstract][Full Text] [Related]
10. Development of early squamous cell carcinoma of the esophagus after endoscopic injection sclerotherapy for esophageal varices. Tanoue K; Hashizume M; Ohta M; Ueno K; Kitano S; Sugimachi K Hepatogastroenterology; 1995; 42(6):792-6. PubMed ID: 8847025 [TBL] [Abstract][Full Text] [Related]
11. Hypercoagulopathy after repeated injection of 5% ethanolamine oleate to sclerose esophageal varices. Hashizume M; Yamaga H; Kitano S; Sugimachi K Hepatogastroenterology; 1990 Dec; 37(6):565-8. PubMed ID: 2289769 [TBL] [Abstract][Full Text] [Related]
12. [Deterioration of liver function following endoscopic injection sclerotherapy of esophageal varices--significance of a new index for liver function "delta TB"]. Matsumoto H; Suzuki F; Souda K; Kitahara H; Kobayashi Y; Tsugiki M; Kawasaki T; Nakao K; Matsumoto M; Iwata K Nihon Shokakibyo Gakkai Zasshi; 1994 Nov; 91(11):2049-55. PubMed ID: 7815720 [TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices. Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786 [TBL] [Abstract][Full Text] [Related]
14. Development of esophageal cancer after endoscopic injection sclerotherapy for esophageal varices: three case reports. Ohta M; Kuwano H; Hashizume M; Sonoda T; Tomikawa M; Higashi H; Ohno S; Watanabe M; Sugimachi K Endoscopy; 1995 Aug; 27(6):455-8. PubMed ID: 8549446 [TBL] [Abstract][Full Text] [Related]
15. [Disturbances of pulmonary gas exchange after sclerotherapy for esophageal varices]. Rusiniak K; Szczepanik AB; Ratajczak J; Meissner AJ Wiad Lek; 1997; 50 Suppl 1 Pt 1():298-302. PubMed ID: 9446371 [TBL] [Abstract][Full Text] [Related]
16. Endoscopic injection sclerotherapy with ligation versus endoscopic injection sclerotherapy alone in the management of esophageal varices: a prospective randomized trial. Shigemitsu T; Yoshida T; Harada T; Takeo Y; Nakamura H; Okita K Hepatogastroenterology; 2000; 47(33):733-7. PubMed ID: 10919021 [TBL] [Abstract][Full Text] [Related]
17. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial. Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917 [TBL] [Abstract][Full Text] [Related]
18. Sequential esophageal motility studies after endoscopic injection sclerotherapy: a prospective investigation. Grande L; Planas R; Lacima G; Boix J; Ros E; Esteve M; Morillas R; Gasull MA Am J Gastroenterol; 1991 Jan; 86(1):36-40. PubMed ID: 1986552 [TBL] [Abstract][Full Text] [Related]
19. Adenosquamous carcinoma of the esophagus after endoscopic variceal sclerotherapy: a case report and review of the literature. Sakata K; Ishida M; Hiraishi H; Sasai T; Watanabe N; Suzuki Y; Masuyama H; Terano A Gastrointest Endosc; 1998 Mar; 47(3):294-9. PubMed ID: 9540886 [No Abstract] [Full Text] [Related]
20. [Renal tubular dysfunction in open pediatric heart surgery--preventive effect of haptoglobin]. Kawai T; Wada Y; Kitaura K; Nakajima S; Enmoto T; Oka T Nihon Kyobu Geka Gakkai Zasshi; 1994 Aug; 42(8):1137-41. PubMed ID: 7963826 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]